Spinal cord stimulation, or SCS, is a small implanted device — think of a pacemaker, but for pain instead of heartbeat — that delivers gentle electrical pulses to the spinal cord to reduce how many pain signals reach your brain. It's used for chronic nerve pain that hasn't responded well to medication, and its defining feature is that you test it before you commit: you wear an external version for several days and judge the relief for yourself before anything permanent is placed.
How it actually works
Pain isn't just something that happens in an injured foot or leg — it's a signal that travels up nerves, through the spinal cord, and into the brain, which is where you actually experience it. Spinal cord stimulation works along that pathway. A thin wire called a lead is placed in the epidural space just outside the spinal cord, and it delivers low-level electrical pulses that change how pain signals are processed before they ever reach the brain.
Researchers describe several overlapping mechanisms: the stimulation appears to "gate" or dampen pain transmission at the level of the spinal cord, engage the body's own descending pain-control pathways, and quiet the overactive nerve signaling that drives chronic pain (mechanisms of action review, PMC/NIH). Different systems use different pulse patterns — traditional low-frequency, high-frequency (10 kHz), and burst stimulation — and each modulates that circuitry in a slightly different way (overview of SCS mechanisms and clinical progress). The practical takeaway is simple: SCS turns down the volume on pain signals rather than numbing you or masking pain with a daily pill.
The trial-before-you-commit design
This is the part that changes the conversation for most patients. You don't agree to an implant and hope it works. Instead, the process happens in two clearly separated stages.
First is the trial. Using imaging guidance, a thin temporary lead is placed through a needle — a procedure much like an epidural, with no incision and nothing implanted. The lead connects to a small external stimulator you wear on your belt or clipped to your clothing. Then you go home and live your normal life for several days to a week: walking, sleeping, doing the things that usually hurt. You are the one who decides whether it meaningfully reduces your pain.
Only if the trial clearly helps do you move to the second stage — a minor outpatient procedure to place a small generator under the skin, connected to permanent leads. If the trial doesn't help enough, the temporary lead is simply removed and you've lost nothing but a week's time. Few treatments for chronic pain let you preview the result this directly, and none of the alternatives that involve cutting, fusing, or removing tissue can be undone the way stimulation can be turned off or taken out.
What the evidence shows
Advocating for a treatment honestly means pointing to the strongest evidence, and for painful diabetic neuropathy that evidence is genuinely strong. In the SENZA-PDN randomized controlled trial, patients whose pain persisted despite medical management were assigned to either continued medication alone or high-frequency (10 kHz) stimulation plus medication. 79% of stimulation patients were responders — meaning at least 50% pain relief — compared with just 5% of the medication-only group (randomized clinical trial, PMC/NIH).
The benefits held up over time. At 24 months, roughly 90% of implanted patients remained responders, and no patients reported worse pain than at baseline (24-month results). On the strength of this and related data, the FDA approved 10 kHz stimulation for painful diabetic neuropathy in 2021. When pain is confined to a single nerve region rather than a broad area, a related approach — peripheral nerve stimulation — follows the same trial-first, reversible logic, and a systematic review found roughly two-thirds of appropriately selected patients achieve at least 50% sustained relief (systematic review of PNS for chronic pain).
It's worth being clear about where this fits. SCS is not a first step. Guidelines still recommend trying medications first, and for some people those work well enough. But the honest counterpoint is that medications have a real ceiling: across neuropathic pain conditions, the number needed to treat for meaningful relief with drugs like pregabalin and gabapentin typically falls between 4 and 10, meaning most people don't get the relief they hoped for (Cochrane review of pregabalin for neuropathic pain). If you're in that group, stimulation is where the evidence points next.
Who it helps — and the medication question
Spinal cord stimulation is designed for people with chronic nerve pain — most commonly painful diabetic neuropathy, nerve pain in the legs or back that persists after spine surgery, and complex regional pain syndrome — whose pain hasn't been adequately controlled by medications. If burning, shooting, or electric-shock pain has cycled you through several drugs without lasting relief, you're the kind of patient this was built for.
One of the goals many patients care about most is getting off, or cutting down on, medications like gabapentin, pregabalin (Lyrica), and opioids. Effective stimulation often makes that possible. Two important cautions, though: never stop or reduce these medications on your own, and never do it abruptly — gabapentin and pregabalin in particular should always be tapered slowly under the guidance of your prescriber to avoid withdrawal effects. Any change should be planned with your care team as the stimulation takes over.
If you're wondering whether this fits your situation, our 2-minute neuropathy assessment is a plain-language starting point, and you can read more about the treatments we offer for nerve pain, including how the trial phase works in practice.
